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Salim Yusuf, MD, DPHILyT he World Health Organization (WHO) and itsmember states have agreed to a shared goalof reducing the risk of premature (age <70
years) mortality from noncommunicable, chronic dis-
eases, including cardiovascular diseases, by 25% by
2025. This “25  25” goal is supported by the World
Heart Federation (WHF) and includes quantitative
targets for risk factors (tobacco, raised blood pres-
sure, obesity, high salt intake, and unhealthy use of
alcohol) and health systems (treatment of high-risk
individuals with drugs and counseling and availabil-
ity of essential drugs and technologies) (1,2). If cur-
rent trends were to continue to 2025, then the risk
of premature mortality from noncommunicable dis-
eases would decrease by only about 10%—hence, the
importance of the aggressive 25% goal (3).
TRAINING TO ACHIEVE “25 3 25”
An amplemenu of policy options is offered formember
states and international partners to help achieve the
“25  25” goal. The WHO’s Global Action Plan for
the Prevention and Control of Non-Communicable
Diseases 2013–2020 recommends, “strengthen(ing)tern University
pulation Health
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and inaugural
g Leaders pro-
n (Dr. Yusuf).international cooperation for resource mobilization,
capacity-building, health workforce training” (1).
Existing training efforts within the international
cardiovascular research community have largely
emphasized skill development in epidemiology and
prevention research, given the state of the science
and the global shortage of investigators with these
critical skills (4). We believe that these training activ-
ities, which have been ongoing for more than 4 de-
cades, should be complemented with new training
activities that emphasize implementation science,
health systems, and health policy research. Also, a
new WHF initiative for such training, with the goal
of building capacity to implement strategies and pol-
icies for global cardiovascular disease prevention
and control, is described in the following text.
GLOBAL GAPS DESPITE SHARED
RISK FACTORS AND INTERVENTIONS
Data from the INTERHEART (5) and INTERSTROKE
(6) case-control studies, as well as the Global Burden
of Disease Study (7), demonstrate that #10 common
modiﬁable factors account for the majority of risk
associated with acute myocardial infarction, stroke,
and cardiovascular morbidity and mortality across
a wide range of countries. The practice of healthy
behaviors throughout one’s life, including avoidance
of tobacco and maintenance of healthy diet, regular
physical activity, and desirable body weight, leads to
a lower incidence of cardiovascular risk factors,
better cardiovascular health, fewer clinical events,
and better health-related quality of life even among
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1372those who have survived a major cardiovascular
event. Drug therapy for treatment of raised blood pre-
ssure and cholesterol has been shown consistently
to reduce cardiovascular events in both primary and
secondary prevention settings.
These strategies for improving cardiovascular
health are supported by a robust body of evidence
established over the past 50 years; yet, their uptake
remains far from optimal, particularly in low- and
middle-income countries (8). Strengthened health
system arrangements and effective implementation
of such health policies as universal health coverage
and the Framework Convention for Tobacco Control
are important strategies for improving population-
level health. Yet, to date, these strategies have not
been adopted widely enough nor implemented at
sufﬁcient scale to realize their full potential impact.
WHF ’S EMERGING LEADERS PROGRAM
In response to these persistent gaps in translating
research evidence into personal and clinical practices
and more effective health systems and policies glob-
ally, the WHF has established the Emerging Leaders
Program to provide high-level training in imple-
mentation science, health systems research, and
health policy research (9). Over the next decade, this
program will train at least 5 cohorts of approximately
25 individuals/cohort—ultimately, leading to>125 par-
ticipants selected to represent at least 50 countries.
These individuals will have demonstrated long-term
promise previously by their early career success, crea-
tivity, and passion for improving cardiovascular health
and preventing cardiovascular disease. As a conse-
quence of their participation in the Emerging Leaders
Program, they will have the capacity to effect change
over the remainder of their careers, well beyond 2025.
The Emerging Leaders Program utilizes adult
learning theory to encourage “learning by doing”
across 3 core components: 1) 10 web-based learningmodules with interactive learning objectives; 2)
a 5-day, face-to-face think tank seminar for creation
of 3 inter-related research proposals, each addressing
a common “25  25” theme—1 each in implementa-
tion science, health systems research, and health
policy research; and 3) pilot funding for promising
proposals to initiate global and regional research
collaboration among the Emerging Leaders.
Feedback from the initial cohort of Emerging
Leaders, who participated in the ﬁrst seminar hosted
by one of us (S.Y.) at McMaster University in Hamil-
ton, Ontario, Canada, in 2014, conﬁrms our assess-
ment that this format was highly effective: it led to
the initiation of 3 linked, global collaborative pilot
projects to increase access and use of essential med-
icines for secondary prevention of cardiovascular
diseases. In March 2015, Dr. J. Jaime Miranda at Uni-
versidad Peruana Cayetano Heredia in Lima, Peru,
will host the 2015 cohort’s think tank seminar,
focusing on raised blood pressure. Between the 2014
and 2015 cohorts, the WHF has already selected 52
Emerging Leaders from 21 countries through a
competitive selection process. Future cohorts also
will focus on tobacco control, which is a third focal
area shared by the WHO and the WHF.
WHF’s Emerging Leaders Program aims to increase
capacity for implementation science, health systems
research, and health policy research to achieve the
ambitious, global “25  25” goal, speciﬁcally in car-
diovascular health promotion and disease preven-
tion. The research collaboration of the ﬁrst cohort of
trainees is progressing as planned, the second co-
hort’s training is well under way, and we are enthu-
siastic about the future development of the program.
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